AU7545998A - Treatment of osteoporosis - Google Patents
Treatment of osteoporosisInfo
- Publication number
- AU7545998A AU7545998A AU75459/98A AU7545998A AU7545998A AU 7545998 A AU7545998 A AU 7545998A AU 75459/98 A AU75459/98 A AU 75459/98A AU 7545998 A AU7545998 A AU 7545998A AU 7545998 A AU7545998 A AU 7545998A
- Authority
- AU
- Australia
- Prior art keywords
- osteoporosis
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/25—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Endocrinology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL12095597A IL120955A0 (en) | 1997-05-30 | 1997-05-30 | Treatment of osteoporosis |
| IL120955 | 1997-05-30 | ||
| PCT/IL1998/000246 WO1998053827A1 (en) | 1997-05-30 | 1998-05-28 | Treatment of osteoporosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU7545998A true AU7545998A (en) | 1998-12-30 |
Family
ID=11070199
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU75459/98A Abandoned AU7545998A (en) | 1997-05-30 | 1998-05-28 | Treatment of osteoporosis |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU7545998A (en) |
| IL (1) | IL120955A0 (en) |
| WO (1) | WO1998053827A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005027913A1 (en) * | 2003-09-19 | 2005-03-31 | Pfizer Products Inc. | Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and a growth hormone secretagogue |
| WO2017147420A1 (en) * | 2016-02-25 | 2017-08-31 | The University Of Florida Research Foundation, Inc. | Methods and compositions with vitamin d compounds for treatment of cystic fibrosis and respiratory disorders |
| CN113181193A (en) * | 2021-05-08 | 2021-07-30 | 黄彬 | Application of calcipotriol as skin external-use medicine for preventing and treating senile osteoporosis |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4330537A (en) * | 1977-12-07 | 1982-05-18 | The Procter & Gamble Company | Compositions for inhibiting mobilization of calcium phosphate in animal tissue |
| IL74617A (en) * | 1985-03-15 | 1988-11-15 | Yeda Res & Dev | Compositions comprising a vitamin d derivative and method for the local treatment of bone fractures in animals |
| US5317017A (en) * | 1992-09-30 | 1994-05-31 | Merck & Co., Inc. | N-biphenyl-3-amido substituted benzolactams stimulate growth hormone release |
| GB2273046A (en) * | 1992-12-02 | 1994-06-08 | Merck & Co Inc | Synergistic combination to improve secretion of endogenous growth hormone |
| US5606054A (en) * | 1993-12-14 | 1997-02-25 | Merck & Co., Inc. | Heterocyclic-fused lactams promote release of growth hormone |
-
1997
- 1997-05-30 IL IL12095597A patent/IL120955A0/en unknown
-
1998
- 1998-05-28 WO PCT/IL1998/000246 patent/WO1998053827A1/en not_active Ceased
- 1998-05-28 AU AU75459/98A patent/AU7545998A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO1998053827A1 (en) | 1998-12-03 |
| IL120955A0 (en) | 1997-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU9469198A (en) | New improved formulation for treatment of osteoporosis | |
| PL328831A1 (en) | Combined treatment of osteoporosis | |
| GB9407135D0 (en) | Treatment of osteoporosis | |
| AU1139095A (en) | Combination treatment for osteoporosis | |
| AU3891299A (en) | Combination therapy for treatment of depression | |
| AUPO907697A0 (en) | Chemical supplementation of bone | |
| AUPO871397A0 (en) | Improved treatment of hides | |
| AU6883398A (en) | Methods of treating bone loss | |
| AU7545998A (en) | Treatment of osteoporosis | |
| AU8817098A (en) | Treatment of liquid waste | |
| AU8102498A (en) | Preparation of diaryl-benzopyrans | |
| AU696976B2 (en) | Effluent treatment | |
| AU3817899A (en) | Therapy of atherosclerosis | |
| AUPO108596A0 (en) | Treatment of obesity | |
| AU8557598A (en) | Treatment of fluids | |
| AU6112299A (en) | Treatment of effluents | |
| AU4310397A (en) | Treatment of waste | |
| AUPO598197A0 (en) | Treatment of hides | |
| AU2375297A (en) | Treatment of hides | |
| GB9721978D0 (en) | Treatment of depression | |
| AU2002301576A1 (en) | Treatment of obesity | |
| AUPO900197A0 (en) | Treatment of obesity | |
| AUPP039897A0 (en) | Treatment of obesity | |
| HK1026915A (en) | Treatment of obesity | |
| AU1991199A (en) | A preparation for the treatment of aphtae |